Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MERCK & CO., INC. (MRK)

  • Business News
  • May 29, 2026, 10:45 UTC
  • 2
  • 1 comments

FDA Grants Breakthrough Therapy Designation for Calderasib (MK-1084), an Investigational KRAS G12C Inhibitor, for Certain Patients with Newly Diagnosed Metastatic KRAS G12C-Mutant Non-Small Cell Lung Cancer (NSCLC)

Market reaction Comment Full text

ECONERGY LTD. (ECNR)

  • Business News
  • May 29, 2026, 10:30 UTC
  • 2
  • 1 comments

BONDS 1 - semi-annual weighted interest rate that will be paid on 30.6.26

Market reaction Comment Full text

RANGE RESOURCES CORP (RRC)

  • Business News
  • May 29, 2026, 10:30 UTC
  • 2
  • 1 comments

Range Declares Quarterly Dividend

Market reaction Comment Full text

OUE Healthcare Limited (5WA)

  • Business News
  • May 29, 2026, 10:20 UTC
  • 4
  • 1 comments

OUE Healthcare Limited - Announcement

Market reaction Comment Full text

THC FARMACEUTICALS, INC (CBDG)

  • Business News
  • May 29, 2026, 10:20 UTC
  • 2
  • 1 comments

Compagnie du Cambodge : Modalités de mise à disposition des informations relatives à l’Assemblée générale ordinaire des actionnaires du vendredi 19 juin 2026

Market reaction Comment Full text

NATUZZI S P A (NTZ)

  • Business News
  • May 29, 2026, 10:15 UTC
  • 2
  • 1 comments

Natuzzi Announces Resignation of a Board Member, Pietro Labriola

Market reaction Comment Full text

Ideaya Biosciences Inc (IDYA)

  • Business News
  • May 29, 2026, 10:02 UTC
  • 2
  • 1 comments

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

PRUDENTIAL FINANCIAL INC (PRS)

  • Business News
  • May 29, 2026, 10:01 UTC
  • 2
  • 1 comments

Prosafe SE: Annual General Meeting completed

Market reaction Comment Full text

Natera Inc (NTRA)

  • Business News
  • May 29, 2026, 10:00 UTC
  • 2
  • 1 comments

Natera - Natera Announces Collaboration with Diakonos Oncology forSignatera™ in Refractory Melanoma

Market reaction Comment Full text

IDEAYA BIOSCIENCES, INC. (IDYA)

  • Business News
  • May 29, 2026, 10:00 UTC
  • 3
  • 1 comments

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text
  • Previous
  • 1705
  • 1706
  • 1707
  • 1708
  • 1709
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351097)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192847)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin